These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

652 related items for PubMed ID: 17224049

  • 1. Molecular surveillance of drug-resistance associated mutations of Plasmodium falciparum in south-west Tanzania.
    Schönfeld M, Barreto Miranda I, Schunk M, Maduhu I, Maboko L, Hoelscher M, Berens-Riha N, Kitua A, Löscher T.
    Malar J; 2007 Jan 15; 6():2. PubMed ID: 17224049
    [Abstract] [Full Text] [Related]

  • 2. Therapeutic efficacy of sulfadoxine-pyrimethamine and prevalence of resistance markers in Tanzania prior to revision of malaria treatment policy: Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase mutations in monitoring in vivo resistance.
    Mugittu K, Ndejembi M, Malisa A, Lemnge M, Premji Z, Mwita A, Nkya W, Kataraihya J, Abdulla S, Beck HP, Mshinda H.
    Am J Trop Med Hyg; 2004 Dec 15; 71(6):696-702. PubMed ID: 15642957
    [Abstract] [Full Text] [Related]

  • 3. Field-based evidence for linkage of mutations associated with chloroquine (pfcrt/pfmdr1) and sulfadoxine-pyrimethamine (pfdhfr/pfdhps) resistance and for the fitness cost of multiple mutations in P. falciparum.
    Osman ME, Mockenhaupt FP, Bienzle U, Elbashir MI, Giha HA.
    Infect Genet Evol; 2007 Jan 15; 7(1):52-9. PubMed ID: 16690361
    [Abstract] [Full Text] [Related]

  • 4. Prediction of Plasmodium falciparum resistance to sulfadoxine/pyrimethamine in vivo by mutations in the dihydrofolate reductase and dihydropteroate synthetase genes: a comparative study between sites of differing endemicity.
    Alifrangis M, Enosse S, Khalil IF, Tarimo DS, Lemnge MM, Thompson R, Bygbjerg IC, Rønn AM.
    Am J Trop Med Hyg; 2003 Dec 15; 69(6):601-6. PubMed ID: 14740875
    [Abstract] [Full Text] [Related]

  • 5. Molecular surveillance of Plasmodium falciparum drug resistance markers reveals partial recovery of chloroquine susceptibility but sustained sulfadoxine-pyrimethamine resistance at two sites of different malaria transmission intensities in Rwanda.
    Kateera F, Nsobya SL, Tukwasibwe S, Hakizimana E, Mutesa L, Mens PF, Grobusch MP, van Vugt M, Kumar N.
    Acta Trop; 2016 Dec 15; 164():329-336. PubMed ID: 27647575
    [Abstract] [Full Text] [Related]

  • 6. Patterns of resistance and DHFR/DHPS genotypes of Plasmodium falciparum in rural Tanzania prior to the adoption of sulfadoxine-pyrimethamine as first-line treatment.
    Eriksen J, Mwankusye S, Mduma S, Kitua A, Swedberg G, Tomson G, Gustafsson LL, Warsame M.
    Trans R Soc Trop Med Hyg; 2004 Jun 15; 98(6):347-53. PubMed ID: 15099990
    [Abstract] [Full Text] [Related]

  • 7. Polymorphisms in Plasmodium falciparum dhfr and dhps genes and age related in vivo sulfadoxine-pyrimethamine resistance in malaria-infected patients from Nigeria.
    Happi CT, Gbotosho GO, Folarin OA, Akinboye DO, Yusuf BO, Ebong OO, Sowunmi A, Kyle DE, Milhous W, Wirth DF, Oduola AM.
    Acta Trop; 2005 Sep 15; 95(3):183-93. PubMed ID: 16023986
    [Abstract] [Full Text] [Related]

  • 8. Frequencies distribution of dihydrofolate reductase and dihydropteroate synthetase mutant alleles associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum population from Hadhramout Governorate, Yemen.
    Bamaga OA, Mahdy MA, Lim YA.
    Malar J; 2015 Dec 22; 14():516. PubMed ID: 26693691
    [Abstract] [Full Text] [Related]

  • 9. Molecular monitoring of Plasmodium falciparum resistance to antimalarial drugs after adoption of sulfadoxine-pyrimethamine plus artesunate as the first line treatment in Iran.
    Afsharpad M, Zakeri S, Pirahmadi S, Djadid ND.
    Acta Trop; 2012 Jan 22; 121(1):13-8. PubMed ID: 22001304
    [Abstract] [Full Text] [Related]

  • 10. Increased prevalence of pfdhfr and pfdhps mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from Jazan Region, Southwestern Saudi Arabia: important implications for malaria treatment policy.
    Madkhali AM, Al-Mekhlafi HM, Atroosh WM, Ghzwani AH, Zain KA, Abdulhaq AA, Ghailan KY, Anwar AA, Eisa ZM.
    Malar J; 2020 Dec 02; 19(1):446. PubMed ID: 33267841
    [Abstract] [Full Text] [Related]

  • 11. High-level Plasmodium falciparum sulfadoxine-pyrimethamine resistance with the concomitant occurrence of septuple haplotype in Tanzania.
    Baraka V, Ishengoma DS, Fransis F, Minja DT, Madebe RA, Ngatunga D, Van Geertruyden JP.
    Malar J; 2015 Nov 05; 14():439. PubMed ID: 26542942
    [Abstract] [Full Text] [Related]

  • 12. Five-year surveillance of molecular markers of Plasmodium falciparum antimalarial drug resistance in Korogwe District, Tanzania: accumulation of the 581G mutation in the P. falciparum dihydropteroate synthase gene.
    Alifrangis M, Lusingu JP, Mmbando B, Dalgaard MB, Vestergaard LS, Ishengoma D, Khalil IF, Theander TG, Lemnge MM, Bygbjerg IC.
    Am J Trop Med Hyg; 2009 Apr 05; 80(4):523-7. PubMed ID: 19346369
    [Abstract] [Full Text] [Related]

  • 13. Associations of antifolate resistance in vitro and point mutations in dihydrofolate reductase and dihydropteroate synthetase genes of Plasmodium falciparum.
    Biswas S.
    J Postgrad Med; 2004 Apr 05; 50(1):17-20. PubMed ID: 15047993
    [Abstract] [Full Text] [Related]

  • 14. [Monitoring the chemoresistance of Plasmodium falciparum malaria in Yopougon (Abidjan): in vivo study of chloroquine sensitivity and evaluation of pyrimethamine resistance following the analysis of point mutation in the dihydrofolate reductase gene].
    Djaman AJ, Basco LK, Mazabraud A.
    Sante; 2002 Apr 05; 12(4):363-7. PubMed ID: 12626289
    [Abstract] [Full Text] [Related]

  • 15. Emergence of an unusual sulfadoxine-pyrimethamine resistance pattern and a novel K540N mutation in dihydropteroate synthetase in Plasmodium falciparum isolates obtained from Car Nicobar Island, India, after the 2004 Tsunami.
    Lumb V, Das MK, Mittra P, Ahmed A, Kumar M, Kaur P, Dash AP, Singh SS, Sharma YD.
    J Infect Dis; 2009 Apr 01; 199(7):1064-73. PubMed ID: 19220141
    [Abstract] [Full Text] [Related]

  • 16. Point mutations in the dihydrofolate reductase and dihydropteroate synthase genes of Plasmodium falciparum and resistance to sulfadoxine-pyrimethamine in Sri Lanka.
    Hapuarachchi HC, Dayanath MY, Bandara KB, Abeysundara S, Abeyewickreme W, de Silva NR, Hunt SY, Sibley CH.
    Am J Trop Med Hyg; 2006 Feb 01; 74(2):198-204. PubMed ID: 16474070
    [Abstract] [Full Text] [Related]

  • 17. Molecular surveillance of mutations in dihydrofolate reductase and dihydropteroate synthase genes of Plasmodium falciparum in Ethiopia.
    Gebru-Woldearegai T, Hailu A, Grobusch MP, Kun JF.
    Am J Trop Med Hyg; 2005 Dec 01; 73(6):1131-4. PubMed ID: 16354825
    [Abstract] [Full Text] [Related]

  • 18. Epidemiology of drug-resistant malaria in Republic of Congo: using molecular evidence for monitoring antimalarial drug resistance combined with assessment of antimalarial drug use.
    Nsimba B, Jafari-Guemouri S, Malonga DA, Mouata AM, Kiori J, Louya F, Yocka D, Malanda M, Durand R, Le Bras J.
    Trop Med Int Health; 2005 Oct 01; 10(10):1030-7. PubMed ID: 16185238
    [Abstract] [Full Text] [Related]

  • 19. Therapeutic efficacy of sulfadoxine-pyrimethamine and the prevalence of molecular markers of resistance in under 5-year olds in Brazzaville, Congo.
    Ndounga M, Tahar R, Basco LK, Casimiro PN, Malonga DA, Ntoumi F.
    Trop Med Int Health; 2007 Oct 01; 12(10):1164-71. PubMed ID: 17956498
    [Abstract] [Full Text] [Related]

  • 20. A molecular epidemiologic study of point mutations for pyrimethamine-sulfadoxine resistance of Plasmodium falciparum isolates from Lao PDR.
    Toma H, Imada Y, Vannachone B, Miyagi M, Kobayashi J, Uechi G, Pethuvang R, Manivong K, Phompida S, Sato Y.
    Southeast Asian J Trop Med Public Health; 2005 May 01; 36(3):602-4. PubMed ID: 16124424
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.